The global prosthetic heart valve market size was US$ 6.9 billion in 2021. The global prosthetic heart valve market size is forecast to reach US$ 19.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period from 2022 to 2030.
A prosthetic heart valve, also known as an artificial heart valve, is implanted in the heart of someone who has the cardiac vascular disease (valvular heart disease). The prosthetic valve is made of robust material like carbon or titanium. The three types of prosthetic heart valves are mechanical heart valves, transcatheter heart valves, and tissue or bio-prosthetic heart valves. In addition, individuals can choose a prosthesis based on their health status and their surgeon's recommendations. Additionally, heart valve replacement involves removing the diseased valve and replacing it with an artificial one.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global prosthetic heart valve market. Several governments worldwide imposed a lockdown in order to prevent the spread of the deadly virus. This postponed the surgical procedure required for establishing prosthetic heart valves and prosthetic heart valve manufacturing for up to six months.
Yet, the need for prosthetic heart valves increased as the people suffering from the virus encountered asthma and cardiovascular disorders as an aftereffect of the contamination directed to gradual market growth.
Regional Analysis
North America garnered a significant market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing medical expertise, unique product launches, and government laws that offer easy access to the production & supervision of cardiac valve devices. In addition, the increasing prevalence of lifestyle diseases such as diabetes and obesity. Thus, these factors are likely to boost the market growth in the region.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the growing prevalence of cardiac disorders like aortic stenosis, the expansion of healthcare infrastructure in countries like China and India. In addition, the continuous emphasis on market players to invest in emerging industries. Therefore, these factors drive the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global prosthetic heart valve market are:
Scope of the Report
The global prosthetic heart valve market segmentation focuses on Product and Region.
Segmentation based on Product
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL PROSTETIC HEART VALVE MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL PROSTETIC HEART VALVE MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL PROSTETIC HEART VALVE MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 MECHANICAL HEART VALVE
5.3 TISSUE HEART VALVE
5.4 TRANSCATHETER HEART VALVE
6 GLOBAL PROSTETIC HEART VALVE MARKET, BY GEOGRAPHY
6.1 OVERVIEW
6.2 NORTH AMERICA
6.2.1 NORTH AMERICA MARKET SNAPSHOT
6.2.2 U.S.
6.2.3 CANADA
6.2.4 MEXICO
6.3 EUROPE
6.3.1 EUROPE MARKET SNAPSHOT
6.3.2 WESTERN EUROPE
6.3.2.1 THE UK
6.3.2.2 GERMANY
6.3.2.3 FRANCE
6.3.2.4 ITALY
6.3.2.5 SPAIN
6.3.2.6 REST OF WESTERN EUROPE
6.3.3 EASTERN EUROPE
6.3.3. 1 POLAND
6.3.3.2 RUSSIA
6.3.3.3 REST OF EASTERN EUROPE
6.4 ASIA PACIFIC
6.4.1 ASIA PACIFIC MARKET SNAPSHOT
6.4.2 CHINA
6.4.3 JAPAN
6.4.4 INDIA
6.4.5 AUSTRALIA & NEW ZEALAND
6.4.6 ASEAN
6.4.6 REST OF ASIA PACIFIC
6.5 MIDDLE EAST & AFRICA
6.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
6.5.2 UAE
6.5.3 SAUDI ARABIA
6.5.4 SOUTH AFRICA
6.5.5 REST OF MEA
6.6 SOUTH AMERICA
6.6.1 SOUTH AMERICA MARKET SNAPSHOT
6.6.2 BRAZIL
6.6.3 ARGENTINA
6.6.4 REST OF SOUTH AMERICA
7 GLOBAL PROSTETIC HEART VALVE MARKET COMPETITIVE LANDSCAPE
7.1 OVERVIEW
7.2 COMPANY MARKET RANKING
7.3 KEY DEVELOPMENT STRATEGIES
8 COMPANY PROFILES
8.1 ABBOT
8.1.1 OVERVIEW
8.1.2 FINANCIAL PERFORMANCE
8.1.3 PRODUCT OUTLOOK
8.1.4 KEY DEVELOPMENTS
8.2 MEDTRONIC
8.2.1 OVERVIEW
8.2.2 FINANCIAL PERFORMANCE
8.2.3 PRODUCT OUTLOOK
8.2.4 KEY DEVELOPMENTS
8.3 MERIL LIFE SCIENCES PVT. LIMITED
8.3.1 OVERVIEW
8.3.2 FINANCIAL PERFORMANCE
8.3.3 PRODUCT OUTLOOK
8.3.4 KEY DEVELOPMENTS
8.4 BOSTON SCIENTIFIC CORPORATION
8.4.1 OVERVIEW
8.4.2 FINANCIAL PERFORMANCE
8.4.3 PRODUCT OUTLOOK
8.4.4 KEY DEVELOPMENTS
8.5 MICRO INTERVENTIONAL DEVICES, INCORPORATED
8.5.1 OVERVIEW
8.5.2 FINANCIAL PERFORMANCE
8.5.3 PRODUCT OUTLOOK
8.5.4 KEY DEVELOPMENTS
8.6 DIRECT FLOW MEDICAL, INCORPORATED
8.6.1 OVERVIEW
8.6.2 FINANCIAL PERFORMANCE
8.6.3 PRODUCT OUTLOOK
8.6.4 KEY DEVELOPMENTS
8.7 EDWARDS LIFESCIENCES CORPORATION
8.7.1 OVERVIEW
8.7.2 FINANCIAL PERFORMANCE
8.7.3 PRODUCT OUTLOOK
8.7.4 KEY DEVELOPMENTS
8.8 LIVANOVA PLC
8.8.1 OVERVIEW
8.8.2 FINANCIAL PERFORMANCE
8.8.3 PRODUCT OUTLOOK
8.8.4 KEY DEVELOPMENTS
8.9 JENAVALVE TECHNOLOGY, INCORPORATED
8.9.1 OVERVIEW
8.9.2 FINANCIAL PERFORMANCE
8.9.3 PRODUCT OUTLOOK
8.9.4 KEY DEVELOPMENTS
8.10 CRYOLIFE, INCORPORATED
8.10.1 OVERVIEW
8.10.2 FINANCIAL PERFORMANCE
8.10.3 PRODUCT OUTLOOK
8.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved